Search
Powered By HealthLine
Health Tools
 A-Z Symptoms
 Health Centers
 Check A Symptom
 Stress Test
 Health Library
Featured Conditions
 Caregiver
 Skin Care
 Food & Fitness
 Diet & Exercise
Resources
Healthscout News
3D Health Animations
Health Videos
Quizzes & Tools
Health Encyclopedia
In-Depth Reports
Library & Communities
News Archive
Drug Library
Find a Therapist
Enter City or Zip Code:
Powered by Psychology Today
PR Newswire
 Read latest







Channels
Home |  Today | Women| Men| Kids| Seniors| Diseases| Addictions| Sex & Relationships| Diet, Fitness, Looks| Alternative Medicine| Drug Checker
Drug DescriptionSide Effects & Drug InteractionsWarnings & Precautions
Clinical PharmacologyOverdosage & ContraindicationsIndications & DosagePatient Info

Fosamax

[Alendronate]

Parafollicular cell (thyroid) adenomas were increased in high-dose male rats (p= 0.003) in a 2-year oral carcinogenicity study at doses of 1 and 3.75 mg/ kg body weight. These doses are equivalent to 0.26 and 1 times a 40 mg human daily dose based on surface area, mg/ m 2 . The relevance of this finding to humans is unknown. Alendronate was not genotoxic in the in vitro microbial mutagenesis assay with and without metabolic activation, in an in vitro mammalian cell mutagenesis assay, in an in vitro alkaline elution assay in rat hepatocytes, and in an in vivo chromosomal aberration assay in mice. In an in vitro chromosomal aberration assay in Chinese hamster ovary cells, however, alendronate gave equivocal results. Alendronate had no effect on fertility (male or female) in rats at oral doses up to 5 mg/ kg/ day (1. 3 times a 40 mg human daily dose based on surface area, mg/ m 2 ).

Pregnancy

Pregnancy Category C:

Text Continues Below



Reproduction studies in rats showed decreased postimplantation survival at 2 mg/ kg/ day and decreased body weight gain in normal pups at 1 mg/ kg/ day. Sites of incomplete fetal ossification were statistically significantly increased in rats beginning at 10 mg/ kg/ day in vertebral (cervical, thoracic, and lumbar), skull, and sternebral bones. The above doses ranged from 0.26 times (1 mg/ kg) to 2.6 times (10 mg/ kg) a maximum recommended daily dose of 40 mg (Paget's disease) based on surface area, mg/ m 2 . No similar fetal effects were seen when pregnant rabbits were treated at doses up to 35 mg/ kg/ day (10.3 times a 40 mg human daily dose based on surface area, mg/ m 2 ). Both total and ionized calcium decreased in pregnant rats at 15 mg/ kg/ day (3. 9 times a 40 mg human daily dose based on surface area, mg/ m 2 ) resulting in delays and failures of delivery. Protracted parturition due to maternal hypocalcemia occurred in rats at doses as low as 0.5 mg/ kg/ day (0. 13 times a 40 mg human daily dose based on surface area, mg/ m 2 ) when rats were treated from before mating through gestation.

Page:  << Prev | 1 | 2 | 3 | 4 | Next >>







HealthScout is a part of HealthCentral
About Us   Our Blog   Contact Us   Privacy Policy   Terms of Use   Site Map  
Copyright © 2001-2013. The HealthCentralNetwork, Inc. All rights reserved.
Advertising Policy   Editorial Policy Advertise With Us   Anti-Spam Policy   PR Newswire